253 related articles for article (PubMed ID: 1617318)
1. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
Labar B; Bogdanić V; Nemet D; Mrsić M; Vrtar M; Grgić-Markulin L; Kalenić S; Vujasinović S; Presecki V; Jakić-Razumović J
Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
3. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
4. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
5. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
6. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
Anderson JE; Appelbaum FR; Schoch G; Barnett T; Chauncey TR; Flowers ME; Storb R
Biol Blood Marrow Transplant; 2001; 7(3):163-70. PubMed ID: 11302550
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
8. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
9. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Kabisch H; Jaburg N; Löliger C; Krüll A; Zander AR
Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
Sutton L; Kuentz M; Cordonnier C; Blaise D; Devergie A; Guyotat D; Leblond V; Flesch M; Bordigoni P; Attal M
Bone Marrow Transplant; 1993 Dec; 12(6):583-9. PubMed ID: 8136742
[TBL] [Abstract][Full Text] [Related]
11. HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI.
Willemze AJ; Geskus RB; Noordijk EM; Kal HB; Egeler RM; Vossen JM
Bone Marrow Transplant; 2007 Aug; 40(4):319-27. PubMed ID: 17572715
[TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
[TBL] [Abstract][Full Text] [Related]
13. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.
Helenglass G; Powles RL; McElwain TJ; Lakhani A; Milan S; Gore M; Nandi A; Zuiable A; Perren T; Forgeson G
Bone Marrow Transplant; 1988 Jan; 3(1):21-9. PubMed ID: 3048467
[TBL] [Abstract][Full Text] [Related]
14. Interstitial pneumonitis after allogeneic bone marrow transplantation following total body irradiation.
Kurisu K; Taniguchi M; Kamikonya N; Hishikawa Y; Miura T; Inoue N; Kanamaru A; Kakishita E; Kai S; Hara H
Radiat Med; 1991; 9(3):118-21. PubMed ID: 1656487
[TBL] [Abstract][Full Text] [Related]
15. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
16. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
Schmitz N; Kayser W; Gassmann W; Euler HH; Wüstemann M; Brix F; Dühmke E; Hebbinghaus D; Gremmel H; Schaub J
Dtsch Med Wochenschr; 1985 Sep; 110(39):1488-93. PubMed ID: 3896727
[TBL] [Abstract][Full Text] [Related]
17. Total body irradiation in bone marrow transplantation: fractionated vs single dose. Acute toxicity and preliminary results.
Valls A; Grañena A; Carreras E; Ferrer E; Algara M
Bull Cancer; 1989; 76(8):797-804. PubMed ID: 2695178
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors affecting leukemia relapse after allogeneic BMT conditioned with cyclophosphamide and fractionated TBI.
Zapatero A; Martín de Vidales C; Pinar B; Rodríguez F; Marín A; Cerezo L; Domínguez P; Pérez Torrubia A
Bone Marrow Transplant; 1996 Sep; 18(3):591-6. PubMed ID: 8879623
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
